Related Experiment Video

Updated: Aug 5, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

Renal-pancreatic-hepatic dysplasia in siblings

D L Blowey1, B A Warady, D L Zwick

  • 1Division of Nephrology, Children's Mercy Hospital, University of Missouri at Kansas City 64108, USA.

Pediatric Nephrology (Berlin, Germany)
|February 1, 1995
PubMed

Insights

This study reports on two brothers with a rare condition called complete renal-pancreatic-hepatic dysplasia. New associated findings, including hypertrophic cardiomyopathy and pancreatic exocrine insufficiency, were observed in one sibling.

Area of Science:

  • Pediatric Genetics
  • Rare Diseases
  • Developmental Biology

Background:

  • Complete renal-pancreatic-hepatic dysplasia is an extremely rare congenital disorder.
  • Fewer than 20 cases have been documented globally since its initial description in 1959.
  • The condition affects multiple organ systems, leading to severe developmental abnormalities.

Observation:

  • The current report details two affected brothers, highlighting familial occurrence.
  • One sibling presented with hypertrophic cardiomyopathy, a previously undocumented cardiac manifestation.
  • Pancreatic exocrine insufficiency was also noted, representing another novel association with this dysplasia.

Findings:

  • The study expands the known clinical spectrum of complete renal-pancreatic-hepatic dysplasia.
  • It identifies hypertrophic cardiomyopathy and pancreatic exocrine insufficiency as potential associated conditions.
  • This case series underscores the variability and complexity of the dysplasia's presentation.

Implications:

  • These findings may aid in earlier diagnosis and improved management strategies for affected children.
  • Further research into the genetic and molecular underpinnings of this rare dysplasia is warranted.
  • Understanding these associated findings can inform genetic counseling and prognosis for families.

More Related Videos

A Preclinical Murine Model of Hepatic Metastases06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice07:48

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice

Published on: October 13, 2018

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...